Associate Professor, Department of Biochemistry and Molecular Pharmacology
Associate Professor, Department of Neurology
Dr. Ueberheide joined the faculty of NYU as the Director of the Proteomics Core. She will be establishing a fully integrated state of the art mass spectrometry laboratory focusing on proteomics. She has extensive experience in biological mass spectrometry especially method development, mapping of post translational modifications, de novo sequencing, Bottom Up and Top Down strategies, as well as comprehensive protein characterization in complex mixtures. Dr. Ueberheide contributed to a wide range of studies from analyzing chromatin, characterizing venoms, to sequencing of complex antibody mixtures. She received her PhD in chemistry at the University of Virginia where she focused on the study of histone post translational modifications using classical Bottom Up and also Top Down strategies. She joined Rockefeller University in 2006 for her postdoctoral training. There she developed de novo sequencing strategies for analysis of venom components and established techniques to study antibodies isolated from HIV infected long-term non-progressors. In her role as the director of proteomics she will enable the NYU faculty in their research efforts of understanding cellular function by characterizing proteins in a biological context. The current focus of her research is to develop advanced mass- spectrometry based techniques to characterize circulating antibodies and to understand the structure-function relationship of peptide toxins. She utilizes chemical strategies in combination with electron transfer dissociation to increase the biological relevant information obtained from mass spectrometric data.
212-263-2546
430 East 29th Street, Alexandria Bldg. East
8, 860
New York, NY 10016
Associate Professor, Department of Neurology at NYU Grossman School of Medicine
Director, Proteomics Resource Center
PhD from University of Virginia
Cell chemical biology. 2022 May 19; 29(5):854-869.e9
Cancer discovery. 2022 May 02; 12(5):1314-1335
Acta neuropathologica. 2022 May; 143(5):585-599
Acta neuropathologica communications. 2022 Apr 13; 10(1):53
Structure. 2022 Apr 07; 30(4):537-550.e5
Cancer discovery. 2022 Apr 01; 12(4):1022-1045
Science advances. 2022 Mar 25; 8(12):eabk1410
Nature. 2022 Mar; 603(7900):321-327